Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223459299> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4223459299 endingPage "106757" @default.
- W4223459299 startingPage "106757" @default.
- W4223459299 abstract "Patient-reported outcome (PRO) measures are key to reflecting the patient experience and patient perspective when developing new medical devices. The PRO measures used in pivotal clinical trials for investigational medical devices are miscellaneous and diversified.This article analyzes and presents the trend and distribution of the use of PRO measures in the pivotal clinical trials for high-risk medical devices regulated and approved by the United States Food and Drug Administration (FDA) from 2005 to 2018 through Premarket Approval (PMA).As clinical endpoints in pivotal clinical trials, the use of PRO measures in FDA-approved PMA applications for high-risk Class III medical devices significantly increased from September 2005 to December 2018. The percentage of PRO use peaked at the years 2014 and 2015 and remains high till 2018. The most used PRO measure among these PMAs was the 36-Item Short Form Survey quality-of-life questionnaire. Three examples are further elaborated in this article to show how the pivotal clinical trials are designed and analyzed with PRO measures as their clinical endpoints for FDA-regulated high-risk medical devices. The article also reiterates regulatory perspectives and considerations from the FDA.The regulatory perspectives and considerations provided by the FDA on evaluating PRO instruments and design and analysis of pivotal clinical trials with PRO measures should be closely followed in the development process of new medical devices." @default.
- W4223459299 created "2022-04-15" @default.
- W4223459299 creator A5003759585 @default.
- W4223459299 creator A5011877804 @default.
- W4223459299 creator A5070485644 @default.
- W4223459299 creator A5075993010 @default.
- W4223459299 date "2022-05-01" @default.
- W4223459299 modified "2023-10-16" @default.
- W4223459299 title "Pivotal clinical trials with patient-reported outcome measures in premarket approval applications for high-risk medical devices from 2005 to 2018: Review, examples, and regulatory considerations" @default.
- W4223459299 cites W2003071820 @default.
- W4223459299 cites W2009432182 @default.
- W4223459299 cites W2022573697 @default.
- W4223459299 cites W2028590696 @default.
- W4223459299 cites W2081859324 @default.
- W4223459299 cites W2083226031 @default.
- W4223459299 cites W2106396955 @default.
- W4223459299 cites W2106535414 @default.
- W4223459299 cites W2119300079 @default.
- W4223459299 cites W2120488577 @default.
- W4223459299 cites W2131657143 @default.
- W4223459299 cites W2149363023 @default.
- W4223459299 cites W2151256680 @default.
- W4223459299 cites W2565119423 @default.
- W4223459299 cites W2746532823 @default.
- W4223459299 cites W2806596191 @default.
- W4223459299 cites W3034607858 @default.
- W4223459299 cites W4238368202 @default.
- W4223459299 doi "https://doi.org/10.1016/j.cct.2022.106757" @default.
- W4223459299 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35398250" @default.
- W4223459299 hasPublicationYear "2022" @default.
- W4223459299 type Work @default.
- W4223459299 citedByCount "1" @default.
- W4223459299 countsByYear W42234592992023 @default.
- W4223459299 crossrefType "journal-article" @default.
- W4223459299 hasAuthorship W4223459299A5003759585 @default.
- W4223459299 hasAuthorship W4223459299A5011877804 @default.
- W4223459299 hasAuthorship W4223459299A5070485644 @default.
- W4223459299 hasAuthorship W4223459299A5075993010 @default.
- W4223459299 hasConcept C142724271 @default.
- W4223459299 hasConcept C148482608 @default.
- W4223459299 hasConcept C2778917124 @default.
- W4223459299 hasConcept C3018890749 @default.
- W4223459299 hasConcept C502991105 @default.
- W4223459299 hasConcept C512399662 @default.
- W4223459299 hasConcept C535046627 @default.
- W4223459299 hasConcept C545542383 @default.
- W4223459299 hasConcept C71924100 @default.
- W4223459299 hasConceptScore W4223459299C142724271 @default.
- W4223459299 hasConceptScore W4223459299C148482608 @default.
- W4223459299 hasConceptScore W4223459299C2778917124 @default.
- W4223459299 hasConceptScore W4223459299C3018890749 @default.
- W4223459299 hasConceptScore W4223459299C502991105 @default.
- W4223459299 hasConceptScore W4223459299C512399662 @default.
- W4223459299 hasConceptScore W4223459299C535046627 @default.
- W4223459299 hasConceptScore W4223459299C545542383 @default.
- W4223459299 hasConceptScore W4223459299C71924100 @default.
- W4223459299 hasLocation W42234592991 @default.
- W4223459299 hasLocation W42234592992 @default.
- W4223459299 hasOpenAccess W4223459299 @default.
- W4223459299 hasPrimaryLocation W42234592991 @default.
- W4223459299 hasRelatedWork W1999590747 @default.
- W4223459299 hasRelatedWork W2017527474 @default.
- W4223459299 hasRelatedWork W2046194993 @default.
- W4223459299 hasRelatedWork W2047254124 @default.
- W4223459299 hasRelatedWork W2123902435 @default.
- W4223459299 hasRelatedWork W2416510479 @default.
- W4223459299 hasRelatedWork W2923890311 @default.
- W4223459299 hasRelatedWork W3080157882 @default.
- W4223459299 hasRelatedWork W4223459299 @default.
- W4223459299 hasRelatedWork W4296343070 @default.
- W4223459299 hasVolume "116" @default.
- W4223459299 isParatext "false" @default.
- W4223459299 isRetracted "false" @default.
- W4223459299 workType "article" @default.